Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Apellis Pharmaceuticals (APLS) Q1 2026 Earnings
APLS
24
Feb
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.74
0.06
0.87
1.67
Details
Expected EPS
-0.374009
Actual EPS
-0.47
Surprise EPS
-0.1
Surprise Percent
+25.67%
Description
Apellis Pharmaceuticals (APLS) has reported earnings of -0.47 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login